ArticleNature communications2026

Intrathecal CRISPR-edited allogeneic IL-13Rα2 CAR T Cells for recurrent high-grade Glioma: preclinical characterization and phase I trial.

Xuetao Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.